Differential binding modes of the bromodomains of CREB-binding protein (CBP) and p300 with acetylated MyoD

Biochemical and Biophysical Research Communications

Volumn 368, Issue 2, 2008, Pages 279-284

  Wei, Lanlan ^a,b   Jamonnak, Nuttara ^a   Choy, Jeremy ^a   Wang, Zhenghe ^c   Zheng, Weiping ^a  

^a UNIVERSITY OF AKRON   (United States)

^b HARBIN MEDICAL UNIVERSITY   (China)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acetylated MyoD; Binding; Bromodomain; CBP; p300

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; MYOD PROTEIN; PROTEIN P300;

ACETYLATION; ARTICLE; BINDING AFFINITY; CELL CYCLE PROGRESSION; DENSITOMETRY; GENETIC TRANSCRIPTION; METABOLISM; PEPTIDE SYNTHESIS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION;

ACETYLATION; BINDING SITES; CREB-BINDING PROTEIN; MYOD PROTEIN; P300-CBP TRANSCRIPTION FACTORS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY;

EID: 39549084931     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.01.071     Document Type: Article

References (29)

1. Yang X.J., and Seto E. HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention. Oncogene 26 (2007) 5310-5318
2. Glozak M.A., and Seto E. Histone deacetylases and cancer. Oncogene 26 (2007) 5420-5432
3. Hodawadekar S.C., and Marmorstein R. Chemistry of acetyl transfer by histone modifying enzymes: structure, mechanism and implications for effector design. Oncogene 26 (2007) 5528-5540
4. Batta K., Das C., Gadad S., Shandilya J., and Kundu T.K. Reversible acetylation of non histone proteins: role in cellular function and disease. Subcell. Biochem. 41 (2007) 193-212
5. Shahbazian M.D., and Grunstein M. Functions of site-specific histone acetylation and deacetylation. Annu. Rev. Biochem. 76 (2007) 75-100
6. Saunders L.R., and Verdin E. Sirtuins: critical regulators at the crossroads between cancer and aging. Oncogene 26 (2007) 5489-5504
7. Mujtaba S., Zeng L., and Zhou M.M. Structure and acetyl-lysine recognition of the bromodomain. Oncogene 26 (2007) 5521-5527
8. Yang X.J. Lysine acetylation and the bromodomain: a new partnership for signaling. Bioessays 26 (2004) 1076-1087
9. Berkes C.A., and Tapscott S.J. MyoD and the transcriptional control of myogenesis. Semin. Cell Dev. Biol. 16 (2005) 585-595
10. Polesskaya A., Duquet A., Naguibneva I., Weise C., Vervisch A., Bengal E., Hucho F., Robin P., and Harel-Bellan A. CREB-binding protein/p300 activates MyoD by acetylation. J. Biol. Chem. 275 (2000) 34359-34364
11. Polesskaya A., and Harel-Bellan A. Acetylation of MyoD by p300 requires more than its histone acetyltransferase domain. J. Biol. Chem. 276 (2001) 44502-44503
12. Duquet A., Polesskaya A., Cuvellier S., Ait-Si-Ali S., Hery P., Pritchard L.L., Gerard M., and Harel-Bellan A. Acetylation is important for MyoD function in adult mice. EMBO Rep. 7 (2006) 1140-1146
13. Sartorelli V., Puri P.L., Hamamori Y., Ogryzko V., Chung G., Nakatani Y., Wang J.Y., and Kedes L. Acetylation of MyoD directed by PCAF is necessary for the execution of the muscle program. Mol. Cell 4 (1999) 725-734
14. Polesskaya A., Naguibneva I., Duquet A., Bengal E., Robin P., and Harel-Bellan A. Interaction between acetylated MyoD and the bromodomain of CBP and/or p300. Mol. Cell. Biol. 21 (2001) 5312-5320
15. Arany Z., Sellers W.R., Livingston D.M., and Eckner R. E1A-associated p300 and CREB-associated CBP belong to a conserved family of coactivators. Cell 77 (1994) 799-800
16. Arany Z., Newsome D., Oldread E., Livingston D.M., and Eckner R. A family of transcriptional adaptor proteins targeted by the E1A oncoprotein. Nature 374 (1995) 81-84
17. Lundblad J.R., Kwok R.P.S., Laurance M.E., Harter M.L., and Goodman R.H. Adenoviral E1A-associated protein p300 as a functional homologue of the transcriptional co-activator CBP. Nature 374 (1995) 85-88
18. Fonte C., Trousson A., Grenier J., Schumacher M., and Massaad C. Opposite effects of CBP and p300 in glucocorticoid signaling in astrocytes. J. Steroid. Biochem. Mol. Biol. 104 (2007) 220-227
19. Kasper L.H., Fukuyama T., Biesen M.A., Boussouar F., Tong C., de Pauw A., Murray P.J., van Deursen J.M., and Brindle P.K. Conditional knockout mice reveal distinct functions for the global transcriptional coactivators CBP and p300 in T-cell development. Mol. Cell. Biol. 26 (2006) 789-809
20. Ma H., Nguyen C., Lee K.S., and Kahn M. Differential roles for the coactivators CBP and p300 on TCF/beta-catenin-mediated survivin gene expression. Oncogene 24 (2005) 3619-3631
21. Kalkhoven E. CBP and p300: HATs for different occasions. Biochem. Pharmacol. 68 (2004) 1145-1155
22. Mujtaba S., He Y., Zeng L., Yan S., Plotnikova O., Sachchidanand, Sanchez R., Zeleznik-Le N.J., Ronai Z., and Zhou M.M. Structural mechanism of the bromodomain of the coactivator CBP in p53 transcriptional activation. Mol. Cell 13 (2004) 251-263
23. Wellings D.A., and Atherton E. Standard Fmoc protocols. Methods Enzymol. 289 (1997) 44-67
24. Jeanmougin F., Wurtz J.M., Le Douarin B.P., Chambon P., and Losson R. The bromodomain revisited. Trends Biochem. Sci. 22 (1997) 151-153
25. Manning E.T., Ikehara T., Ito T., Kadonaga J.T., and Kraus W.L. p300 forms a stable, template-committed complex with chromatin: role for the bromodomain. Mol. Cell. Biol. 21 (2001) 3876-3887
26. Candiano G., Bruschi M., Musante L., Santucci L., Ghiggeri G.M., Carnemolla B., Orecchia P., Zardi L., and Righetti P.G. Blue silver: a very sensitive colloidal Coomassie G-250 staining for proteome analysis. Electrophoresis 25 (2004) 1327-1333
27. W.S. Rasband, ImageJ, U.S. National Institutes of Health, Bethesda, Maryland, USA. Available from: , 1997-2007.
28. Pearson-White S.H. Human MyoD: cDNA and deduced amino acid sequence. Nucleic Acids Res. 19 (1991) 1148
29. Jamonnak N., Fatkins D.G., Wei L., and Zheng W. N(epsilon)-methanesulfonyl-lysine as a non-hydrolyzable functional surrogate for N(epsilon)-acetyl-lysine. Org. Biomol. Chem. 5 (2007) 892-896